The potential role of Na-K-ATPase and its signaling n the development of anemia in chronic kidney disease

Chronic kidney disease (CKD) is one of the most prominent diseases affecting our population today. According to the Factsheet published by Centers for Disease Control and Prevention (CDC), it effects approximately 15% of the total population in the United States in some way, shape, or form. Within the myriad of symptomatology associated with CKD, one of the most prevalent factors in terms of affecting quality of life is anemia. Anemia of CKD cannot be completely attributed to one mechanism or cause, but rather has a multifactorial origin in the pathophysiology of CKD. While briefly summarizing well-documented risk factors, this review, as a hypothesis, aims to explore the possible role of Na-K-ATPase and its signaling function [especially recent identified reactive oxygen species (ROS) amplification function] in the interwoven mechanisms of development of the anemia of CKD.

Automated summary

Chronic kidney disease (CKD) is a major disease affecting the population today, with anemia being a significant factor impacting quality of life. The development of anemia in CKD has a multifactorial origin, and this review aims to explore the potential role of Na-K-ATPase's signaling function in the complex mechanisms of anemia development in CKD.